skip to main content columnskip to left navigationskip to horizontal navigation

The Center for Prescription Drug Abuse Prevention and Treatment

College of Public Health


Horn, KA, Pack, RP, Trestman, R, Lawson, G (2018).  Almost everything we need to better serve children of the opioid crisis we learned in the 80s and 90s.  Frontiers in Public Health, 6:289. doi: 10.3389/fpubh.2018.00289 

Mathis, SM, Hagemeier, NE, Hagaman, A, Dreyzehner, J, Pack, RP (2018).  A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States.  Current HIV/AIDS Reports. 15(5) 359-370. doi:10.1007/s11904-018-0409-9 

Wykoff, RW, Pack, RP, Egen O*. (2018) The 12 P’s of the Opioid Epidemic. AJPH. 108, no. 9 (September 1, 2018): pp. 1124-1125. DOI: 10.2105/AJPH.2018.304629

Moorman, JP, Krolikowski, MR, Mathis, SM, Pack, RP (2018) HIV/HCV Co-infection:  Burden of disease and care strategies in Appalachia, Current HIV/AIDS Reports. doi:10.1007/s11904-018-0404-1

Salwan, A.J., Hagemeier, N.E. & Harirforoosh, S. (2018). Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? Clinical Drug Investigation. 38, 573.

Hagemeier, N.E., Click, I.A., Flippin, H, Gilliam H, Basden JA, Carico R, Ross A. (2018).  Pharmacists’ and Prescribers’ Neonatal Abstinence Syndrome (NAS) Prevention Behaviors: A Preliminary Analysis. International Journal of Clinical Pharmacy, 40(1), 20-25

Hagemeier, N. E., Tudiver, F., Brewster, S., Hagy, E. J., Ratliff, B., Hagaman, A., & Pack, R. P. (2018). Interprofessional Prescription Opioid Abuse Communication among Prescribers and Pharmacists: A Qualitative Analysis. Substance Abuse, 39(1), 89–94.

Hagemeier NE, Ventricelli D, Sevak RJ. (2017) Situational communication self-confidence among community pharmacists: A descriptive analysis.  Research in Social and Administrative Pharmacy, 13(6), 1175-1180.

Brooks, B., McBee, M., Pack, R., & Alamian, A. (2017). The effects of rurality on substance use disorder diagnosis: A multiple-groups latent class analysis. Addictive Behaviors, 68, 24-29. doi:10.1016/j.addbeh.2017.01.019

Shah, D., Brown, S., Hagemeier, N., Zheng, S., Kyle, A., Pryor, J., … Singh, P. (2016). Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help? SpringerPlus, 5(1), 854.

Pack, R. P., Hagaman, A., Warfield, S., Gray, J. A., Tudiver, F., Alamian, A., & Hagemeier, N. (2016). Interprofessional Research, Training and Outreach: The ETSU Prescription Drug Abuse/Misuse Working Group. International Journal of Health Sciences Education, 3(2). 

Hagemeier, N. E. (2016). Communicative behavior. In Newton DE ed. Prescription Drug Abuse: A Reference Handbook. Santa Barbara, CA: ABC-CLIO, 136-140.

Hagemeier, N. E., Alamian, A., Murawski, M. M., Flippin, H., Hagy, E. J., & Pack, R. P. (2016). Correlates of Prescription Opioid Legitimacy Judgments Among Community Pharmacists. Subst Use Misuse, 51(6), 692-699. doi:10.3109/10826084.2015.1135952

Hagemeier, N. E., Alamian, A., Murawski, M. M., & Pack, R. P. (2015). Factors associated with provision of addiction treatment information by community pharmacists. J Subst Abuse Treat, 52, 67-72. doi:10.1016/j.jsat.2014.11.006

Hagemeier, N. E., Blevins, S. R., Hagen, K. S., Sorah, E. L., Shah, R. S., Ferris, K. M. (2015). Integration of Rural Community Pharmacies into a Rural Family Medicine Practice-Based Research Network: A Descriptive Analysis. Innovations in Pharmacy, 6(3), e1-e11.

Hagemeier, N. E., Tudiver, F., Brewster, S., Hagy, E. J., Hagaman, A., & Pack, R. P. (2015). Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.Res Social Adm Pharm. doi:10.1016/j.sapharm.2015.12.008

Gray, J., Hagemeier, N., Brooks, B., & Alamian, A. (2015). Prescription disposal practices: A 2-Year ecological study of drug drop box donations in Appalachia. Am J Public Health, 105(9), e89-94. doi:10.2105/ajph.2015.302689

Paterson NE, Frank V, Sevak RJ, Wagreich E, London ED. (2014) Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.Am. J. Drug Alcohol Dep. 40: 19

Hagemeier, N. E., Gray, J. A., & Pack, R. P. (2013). Prescription drug abuse: A comparison of prescriber and pharmacist perspectives.Substance Use & Misuse, 48(9), 761-768.

Hagemeier, N. E., Murawski, M. M., Lopez, N. C., Alamian, A., & Pack, R. P. (2013). Theoretical Exploration of Tennessee Community Pharmacists’ Perceptions Regarding Opioid Pain Reliever Abuse Communication. Research in Social & Administrative Pharmacy. doi:10.1016/j.sapharm.2013.07.004

Stoops WW, Bennetta JA, Lile JA, Sevak RJ, Rush CR. (2013) Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.Prog. Neuropsychopharmacol. Biol. Psychiatry 47:111-117.

Gray, J. A., & Hagemeier, N. E. (2012). Prescription drug abuse and DEA-sanctioned drug take-back events: Characteristics and outcomes in rural Appalachia. Archives of Internal Medicine, 172(15), 1186-1187.

Dean AC, Sevak RJ, Monterosso J, London ED. (2011) Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans.J. Stud. Alcohol. Drugs. 72:943-53.

White, R,  Zullig, KJ, Lander, L, Shockley, C, Pack, RP, Sullivan, CR (2011).Preliminary results of the West Virginia Prescription Drug Abuse Quitline. Health Promotion Practice. Sept 13 2011 epub ahead of print.

Sevak RJ, Vansickel AR, Stoops WW, Hays LR, Rush CR. (2011) Discriminative-stimulus, subject-rated and physiological effects of methamphetamine in humans pretreated with aripiprazole.J. Clin. Psychopharmacology 31(4): 470-480 

Zullig, KJ, Lander, L, White, RJ, Sullivan, CR, Shockley, C, Dong, L, Pack, RP, Surber Fedis, T (2010)  Preliminary Evaluation of the W V Prescription Drug Abuse Quitline. West Virginia Medical Journal 106, 4, 38-46.

Sevak RJ, Stoops WW, Glaser PAE, Hays LR, Rush CR. (2010) Reinforcing effects of d-amphetamine: Influence of novel ratios on a progressive-ratio schedule. Behav. Pharmacol. 21:745-753.

Sevak RJ, Stoops WW, Rush CR. (2010) Behavioral effects of d-amphetamine in humans: Influence of sub clinical levels of inattention and hyperactivity. Am. J. Drug Alc. Abuse 36:220-227.

Rush CR, Stoops WW, Sevak RJ, Hays LR. (2010) Cocaine choice in humans during d-amphetamine maintenance.J. Clin. Psychopharmacology 30(2):152-159.

Lanier, MM, Pack, RP & Akers, TA (2010) Epidemiologic Criminology:  Drug use among gang members. Journal of Correctional Health Care. 16:6-16  (erratum in JCHC 16(3) 250.

Sevak RJ, Stoops WW, Hays LR, Rush CR. (2009) Discriminative-stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans J. Pharmacol. Exp. Ther 328(3):1007-1018.

Pack, RP, Krishnamurthy, G*, Cottrell L, Stanton BF, D'Alessandri, D*, Burns, J (2005)  Caregiver predictors of adolescent inhalant abuse in rural Appalachia.  American Journal of Health Behavior;  29(4):331-341.

Burns, J, Cottrell, L, Perkins, K, Pack, RP, Stanton, BF, Hobbs, G, Hobby, L, Eddy, D, Hauschka, A (2004) Depressive symptoms and risk behaviors among rural adolescents. Pediatrics 113(5),1313-1320 

Rai, A.A., Stanton, B., Wu, Y., Li, X., Galbraith, J., Cottrell, L., Pack, R., Harris, C., D'Alessandri, D., & Burns, J. (2003). The relative influences of perceived parental monitoring and perceived peer involvement on adolescent risk behaviors: An analysis of six cross-sectional data sets. Journal of Adolescent Health, 33(2)  108-118. 

Stanton, BF,Li, X, Pack, RP, Cottrell, L, Harris, CA, Burns, JM (2002). Longitudinal influence of perceptions of peer and parental factors on African American adolescent risk involvement. Journal of Urban Health, 79(4); 536-548. 

Li, X, Stanton, BF, Pack, RP, Harris, CA, Cottrell, L & Burns, J (2002) Risk and Protective factors associated with gang involvement among urban African-American children and adolescents.  Youth and Society, 34(2); 172-194.

Pack, RP, Crosby, RA, St. Lawrence, JS (2001) Associations between adolescents risk behavior and their scores on six psychometric scales.  Journal of HIV/AIDS Prevention and Education for Adolescents and Children 4(1) 33-47

Li, X, Stanton, BF, Cottrell, L, Burns, J, Pack, RP, Kaljee, L (2001) Patterns of initiation of sex and drug-related activities among urban low-income African-American adolescents. Journal of Adolescent Health 28(1), 46-54. 

Zorick T, Sevak RJ, Swanson AM, Miotto K, De La Garza R, Newton T, Shoptaw SS, London ED. (2009) Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J. Exp. Pharmacol. 2:13-18.

Stanton, B, Harris, C, Cottrell, L, Li, X, Gibson, C, Guo, J, Pack, RP, Galbraith, J, Pendleton, S, Wu, Y, Marshall, S (2006) Trial of an urban adolescent risk reduction program for rural youth:  An imperfect fit.  Journal of Adolescent Health.  38(1):55

Stanton, B, Guo, J, Cottrell, L, Galbraith, J, Li, X, Gibson, C, Pack, R,  Cole, M, Marshall, S Harris, C (2005) The complex business of adapting effective interventions to new populations: an urban to rural transfer  Journal of Adolescent Health  37(163):17- 26.

Li, X, Stanton, BF, Galbraith, J, Burns, J, Cottrell, L, Pack, RP (2002). Parental monitoring intervention: Practice makes perfect.  Journal of the National Medical Association 94(5):364-70


icon for left menu icon for right menu